|
Renal clear cell carcinoma with weak to moderate NSE positivity in 30% of tumor cells. |
|
|
Strong NSE immunostaining in all cells of a castration resistant prostate cancer. |
|
|
Strong NSE immunostaining in all cells of a renal clear cell carcinoma. |
|
|
Strong NSE immunostaining in all tumor cells of a seminoma of the testis. |
|